Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,958 | -58,574 | -53,079 | -135,682 | -66,611 |
| Depreciation Amortization | 51 | 3,947 | 3,585 | 2,532 | 1,268 |
| Accounts receivable | 294 | 53,227 | 52,201 | 25,656 | 26,397 |
| Accounts payable and accrued liabilities | -8,418 | -20,969 | 14,281 | 32,532 | 15,137 |
| Other Working Capital | -7,103 | 31,079 | 61,133 | 54,508 | 38,857 |
| Other Operating Activity | 10,975 | -151,679 | -186,851 | -47,898 | -37,102 |
| Operating Cash Flow | $-25,159 | $-142,969 | $-108,730 | $-68,352 | $-22,054 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,686 | 268,000 | 176,303 | 120,852 | 42,778 |
| PPE Investments | -38 | 10,926 | -33 | N/A | N/A |
| Purchase Of Investment | N/A | -58,555 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 160,385 | 160,385 | N/A | N/A |
| Investing Cash Flow | $-17,724 | $380,756 | $336,655 | $120,852 | $42,778 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -216,580 | -210,760 | -643 | -321 |
| Common Stock Issued | 16,947 | 69,970 | N/A | N/A | N/A |
| Common Stock Repurchased | -2,675 | -1,026 | -1,026 | -1,026 | -923 |
| Financing Cash Flow | $14,272 | $-147,636 | $-211,786 | $-1,669 | $-1,244 |
| Beginning Cash Position | 126,263 | 36,112 | 36,112 | 36,112 | 36,112 |
| End Cash Position | 97,652 | 126,263 | 52,251 | 86,943 | 55,592 |
| Net Cash Flow | $-28,611 | $90,151 | $16,139 | $50,831 | $19,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,159 | -142,969 | -108,730 | -68,352 | -22,054 |
| Capital Expenditure | -38 | -87 | -33 | N/A | N/A |
| Free Cash Flow | -25,197 | -143,056 | -108,763 | -68,352 | -22,054 |